Gut health is the number one global food and beverage trend for 2026, named by Innova Market Insights. The market is heading for $105 billion. AI is transforming how it works. Digestion.ai is the domain at the centre of this convergence.
Digestion.ai is a category-defining domain. It is a single, precise, universally understood word that names exactly what the fastest-growing segment of the global health market does. Combined with the .ai extension, it signals the technological future of the field without metaphor or explanation. No tagline required. No brand story needed. The domain is the positioning.
The convergence of gut health and artificial intelligence is already underway. Platforms like ZOE, Viome, and DayTwo are delivering AI-powered personalised nutrition plans based on microbiome sequencing. Danone has opened a dedicated OneBiome Lab combining AI and microbiology. Brightseed uses AI molecular discovery to identify gut health compounds. The category has a clear direction. It lacks a dominant brand.
The domain works across every application in the space. A consumer app. A clinical diagnostics platform. A nutrition brand. A therapeutics company. A research tool. A digital health marketplace. Whatever AI does to digestion over the next decade, Digestion.ai is the address that describes it.
The AI-powered gut health category is forming right now. The company that builds under Digestion.ai will be building under the most authoritative possible address in this space.
A consumer platform delivering personalised nutrition, microbiome tracking, and AI dietary recommendations. ZOE, Viome, and DayTwo have proven the model. Digestion.ai is the name that none of them own. Building under this domain positions a new entrant as the category's natural home.
Perfect fitA clinical or direct-to-consumer platform for gut microbiome sequencing, interpretation, and AI-powered health recommendations. The market for gut microbiome testing kits is projected to reach $2.66 billion by 2035. Digestion.ai is the address clinicians and patients will trust.
Perfect fitA probiotic, prebiotic, or synbiotic brand using AI to personalise formulations. The precision probiotics market is moving from generic blends to strain-specific, function-focused products. A brand under Digestion.ai commands immediate category authority and consumer clarity.
Strong fitA company developing microbiome-based therapeutics for gastrointestinal disorders, metabolic conditions, or mental health. The microbiome therapeutics market grows at 33.67% CAGR through 2034. Digestion.ai is the most clinical, precise domain available in this fast-moving therapeutic space.
Strong fitA B2B platform helping food manufacturers develop gut-health-focused products using AI ingredient analysis, claim substantiation, or consumer insight. With launches in this category up 61% in a single year, the food industry's need for an intelligence platform under this name is clear.
Good fitA single-word .ai domain in the world's number one health trend category, with a 30%+ CAGR microbiome market behind it, clear buyer segments across consumer, clinical, and pharma, and no serious competitor domain. The investment case is as clean as the domain itself.
Good fitThe science, the consumer demand, and the technology are converging simultaneously. The category leader has not yet been named.
No asking price is listed. The right buyer will know its value. We welcome offers from digital health founders, nutrition brands, microbiome researchers, and investors. Every enquiry is read and responded to within 48 hours.